U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT06831773) titled 'Clinical Study of Carbon Ion Radiotherapy for High-grade Glioma' on Feb. 05.
Brief Summary: The objective is to use the advantages of heavy ion physical dosimetry and biology to improve the tumor control rate and long-term survival rate of high-grade glioma, reduce the occurrence of brain tissue radiation damage caused by increasing prescription dose, and provide new treatment suggestions for glioma radiotherapy.
Study Start Date: Feb. 01
Study Type: INTERVENTIONAL
Condition:
Carbon Ion Radiotheray
High-grade Glioma
Heavy Ion Radiotherapy
Intervention:
RADIATION: Carbon ion combined with photon radiotherapy
PTV1 was first tre...